Login to Your Account

Faith In Bio Market Pays Off With Europe's Largest Fund

By Nuala Moran

Wednesday, January 31, 2007
LONDON - Abingworth Management closed Europe's largest ever life sciences venture fund, Abingworth Bioventures V, capping the oversubscribed fund at £300 million (US$586.9 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription